Cathie Wood Recursion Pharmaceuticals, Inc. Transaction History
Ark Investment Management LLC
- $12.1 Billion
- Q2 2025
A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 32,988,631 shares of RXRX stock, worth $178 Million. This represents 1.38% of its overall portfolio holdings.
Number of Shares
32,988,631
Previous 34,815,502
5.25%
Holding current value
$178 Million
Previous $184 Million
9.37%
% of portfolio
1.38%
Previous 1.99%
Shares
17 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
288MCall Options Held
7.77MPut Options Held
5.84M-
Vanguard Group Inc Valley Forge, PA36.1MShares$195 Million0.0% of portfolio
-
Baillie Gifford & CO24.2MShares$131 Million0.1% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$93.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$79.4 Million0.31% of portfolio
-
Kinnevik Ab (Publ) Stockholm, V713.4MShares$72.7 Million100.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $976M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...